Virginia Commonwealth University

VCU Massey Cancer Center

A righteous purpose

“We have a righteous purpose,” says Richard “Rick” Moran, Ph.D., a preeminent scientist at VCU Massey Cancer Center. “I ask my research students to walk through the oncology clinic every day to refresh their memories as to why we are here. The patient is the very real endpoint for research.”

Continue reading →

Massey Cancer Center helps patient be father of the bride at bedside ceremony

Martin Lenhardt, Ph.D., was relegated to bed on Oct. 10, with little to no energy or chance of leaving the hospital in the near future, even for a day. Still, at Virginia Commonwealth University’s Massey Cancer Center, as he lay in bed surrounded by family and friends, he was allowed to play his rightful part as the proud father of the bride to his youngest daughter Megan Kinnison.

Continue reading →

Twitter chat on genomics and precision medicine

Recently, the National Cancer Institute hosted a Twitter on “Genomics and Precision Medicine in Oncology.” VCU Massey Cancer Center medical oncologist Andrew Poklepovic, M.D., who is also a member of the Developmental Therapeutics research program at Massey and assistant professor in the Division of Hematology, Oncology and Palliative Care at the VCU School of Medicine, weighed in as the moderator posed a series of questions.

Continue reading →

Massey scientists uncover process that could drive the majority of cancers

The gene p53 has been described as the “guardian of the genome” due to its prominent role in preventing genetic mutations. More than half of all cancers are thought to originate from p53 mutations or loss of function, and now a recent study by VCU Massey Cancer Center scientist Richard Moran, Ph.D., explains why. 

Continue reading →

Expert Q&A on immunotherapy with Giao Q. Phan

Former President Jimmy Carter announced this week that he is cancer free after undergoing a cutting-edge approach to cancer treatment known as immunotherapy. Massey surgical oncologist and member of the Developmental Therapeutics research program Giao Q. Phan, M.D., F.A.C.S., specializes in immunotherapy and sat down to answer some questions on the subject.

Continue reading →